Table 3.
Ranking probability of interventions.
| Intervention | Clinical effective rate | Visual acuity | Visual field gray value | Microaneurysm volume | Hemorrhage area | Macular thickness | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUCRA (%) | Rank | SUCRA (%) | Rank | SUCRA (%) | Rank | SUCRA (%) | Rank | SUCRA (%) | Rank | SUCRA (%) | Rank | |
| CXC+CD | 54.02 | 6 | 98.51 | 1 | 56.74 | 4 | 73.19 | 2 | 55.29 | 5 | 86.23 | 1 |
| CDDP+CD | 88.58 | 1 | 41.8 | 4 | 59.74 | 3 | 36.45 | 4 | 59.2 | 3 | 80.94 | 2 |
| QG+CD | 66.98 | 3 | 49.27 | 3 | – | – | – | – | – | – | – | – |
| SDMUC+CD | 60.63 | 4 | – | – | – | – | – | – | 86.24 | 1 | 49.94 | 4 |
| MMDHP+CD | 43.56 | 8 | – | – | 67.47 | 2 | 45.87 | 3 | 72.29 | 2 | 57.05 | 3 |
| HXMMT+CD | 40.01 | 9 | – | – | 23.7 | 5 | 94.48 | 1 | 18.67 | 6 | 48.82 | 5 |
| CXC | 39.97 | 10 | – | – | – | – | – | – | – | – | – | – |
| CDDP | 69.27 | 2 | 70.34 | 2 | 91.83 | 1 | – | – | 58.3 | 4 | – | – |
| QG | 57.18 | 5 | – | – | – | – | – | – | – | – | 23.91 | 6 |
| SDMUC | 47.47 | 7 | – | – | – | – | – | – | – | – | – | – |
| DHHYK | 30.04 | 11 | 33.85 | 5 | – | – | – | – | – | – | – | – |
| CD | 2.27 | 12 | 6.25 | 6 | 0.51 | 6 | 0 | 5 | 0 | 7 | 3.11 | 7 |
CD, calcium dobesilate; CXC, Compound Xueshuantong Capsule; CDDP, Compound Danshen Dripping Pill; SDMUC, Shuangdan Mingmu Capsule; QG, Qiming Granule; HXMMT, Hexuemingmu Tablet; DHHYK, Danhong Huayu Koufuye; MMDHP, Mingmu Dihuang Pill, -: no value.